Healthcare & Biotechnology stocks

Is This the Final Top for Gilead Sciences? Since its IPO in January 1992, Gilead Sciences has established a long-term

Historical buying chance for this stock. Since 2022, Hims & Hers Health stock started its first bullish impulses within green

This stock presents a significant long-term opportunity. Since its IPO on October 26, 1984, UnitedHealth Group has developed a technically

A Big Cycle Correction Since its IPO in 1981, Novo Nordisk has followed a massive bull run. After forming green